Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares following the Q3 report.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- 3 Best Stocks to Buy Now, 11/4/2024, According to Top Analysts
- Viking Therapeutics surges after presenting ‘promising’ obesity drug data
- Eli Lilly price target lowered to $1,015 from $1,025 at Deutsche Bank
- Eli Lilly earnings selloff brings buying opportunity, says JPMorgan
- Eli Lilly price target lowered to $1,100 from $1,150 at BofA